Benjamin Edwards Inc Gilead Sciences, Inc. Transaction History

Benjamin Edwards Inc

$6.71 Billion
Q3 2024

A detailed history of Benjamin Edwards Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Benjamin Edwards Inc holds 365,820 shares of GILD stock, worth $33.8 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares

365,820

Previous 17,925 1940.84%

Holding current value

$33.8 Million

Previous $1.23 Million 2392.93%

% of portfolio

0.46%

Previous 0.24%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $23.2 Million - $29.2 Million	347,895 Added 1940.84%	365,820 $30.7 Million
Q2 2024 Aug 12, 2024	BUY	$63.15 - $72.88 $7,893 - $9,110	125 Added 0.7%	17,925 $1.23 Million
Q1 2024 Apr 29, 2024	SELL	$71.58 - $87.29 $40,227 - $49,056	-562 Reduced 3.06%	17,800 $1.3 Million
Q4 2023 Feb 06, 2024	SELL	$73.27 - $83.09 $273,663 - $310,341	-3,735 Reduced 16.9%	18,362 $1.49 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $44,881 - $48,966	-607 Reduced 2.67%	22,097 $1.66 Million
Q2 2023 Aug 15, 2023	SELL	$76.01 - $86.7 $320,610 - $365,700	-4,218 Reduced 15.67%	22,704 $1.75 Million
Q1 2023 Apr 27, 2023	BUY	$77.31 - $88.08 $77,387 - $88,168	1,001 Added 3.86%	26,922 $2.23 Million
Q4 2022 Feb 07, 2023	BUY	$62.32 - $89.47 $49,108 - $70,502	788 Added 3.14%	25,921 $2.23 Million
Q3 2022 Oct 28, 2022	SELL	$59.54 - $68.01 $8,454 - $9,657	-142 Reduced 0.56%	25,133 $1.55 Million
Q2 2022 Aug 12, 2022	BUY	$57.72 - $65.01 $181,991 - $204,976	3,153 Added 14.25%	25,275 $1.56 Million
Q1 2022 May 04, 2022	BUY	$57.92 - $72.58 $267,648 - $335,392	4,621 Added 26.4%	22,122 $1.32 Million
Q4 2021 Feb 07, 2022	BUY	$64.88 - $73.64 $95,698 - $108,619	1,475 Added 9.2%	17,501 $1.27 Million
Q3 2021 Nov 02, 2021	BUY	$67.69 - $73.03 $56,453 - $60,907	834 Added 5.49%	16,026 $1.12 Million
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $9,203 - $10,055	-145 Reduced 0.95%	15,192 $1.05 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $9,180 - $10,474	153 Added 1.01%	15,337 $991,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $281,040 - $320,232	4,961 Added 48.53%	15,184 $885,000
Q3 2020 Nov 16, 2020	SELL	$62.1 - $78.08 $15,462 - $19,441	-249 Reduced 2.38%	10,223 $646,000
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $155,965 - $181,104	2,156 Added 25.93%	10,472 $806,000
Q1 2020 May 07, 2020	BUY	$62.63 - $80.22 $377,784 - $483,887	6,032 Added 264.1%	8,316 $622,000
Q4 2019 Feb 06, 2020	BUY	$61.62 - $67.78 $246 - $271	4 Added 0.18%	2,284 $148,000
Q3 2019 Nov 05, 2019	BUY	$62.51 - $69.0 $6,876 - $7,590	110 Added 5.07%	2,280 $145,000
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $17,818 - $19,981	288 Added 15.3%	2,170 $147,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $117,681 - $131,834	1,882 New	1,882 $122,000

Others Institutions Holding GILD

# of Institutions

1,925

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Account

Benjamin Edwards Inc Gilead Sciences, Inc. Transaction History